Eppendorf Starts Off 2018 Introducing Two New Benchtop CentrifugesApril 18th, 2018
Boost Your Lab’s Testing Capabilities with the Medica EasyBloodGas SystemApril 13th, 2018
AACC Annual Scientific Meeting and Clinical Lab Expo
ChicagoBooth No.: 3849
Medlab - The World’s Largest Expo
DubaiBooth No.: Z5 G 42
MEDICA 2017 - World Forum for Medicine
Düsseldorf, GermanyBooth No.: 3/D35-2
69th AACC Annual Meeting and Clinical Lab Expo - July 30 - August 3, 2017
SAN DIEGO, CA, USA
Thanks to Block Scientific, I was able to procure the re-certified Bayer DCA 2000+ without hassles and get the lab back in operation. The
device works perfectly and I look forward to doing more business with Block Scientific.
--- Mathew Anderson, New Jersey
These kits are intended for use by appropriately trained and qualified personnel for the detection of antibodies to P.falciparum, P.vivax, P.ovale and P.malariae in human serum and plasma.
The Malaria ELISA use four recombinant antigens in a sandwich test to produce a test that is both highly specific and sensitive. The antigens will detect P.falciparum, P.vivax, P.ovale and P.malariae -specific IgG, IgM, and IgA; enabling the test to detect antibodies during all stages of infection. All reagents except the Conjugate and Wash solution are supplied ready to use and colour-coded, and the procedure uses undiluted samples and standard volumes for ease of both
manual and automated use. The assay can be used with both serum and plasma.
The plastic wells are coated with a mixture of P. falciparum and P. vivax recombinant antigens. The antigenic similarity between Plasmodium species means that antibodies to all species can be detected. Specific antibodies in serum or plasma specimens combine with these antigens and with the same antigens conjugated to horseradish peroxidase, when conjugate is added to a well in which the specimen has been incubated.
After unreacted material has been removed by washing, the presence of bound enzyme indicating the presence in the specimen of specific antibodies is revealed by a colour change in
the substrate/chromogen mixture. The intensity of the colour is compared to that in control wells to determine the presence or absence of specific antibody.